Evidence map›Paper›PMID 38149860›Full record

ArticleMicrobiology spectrum2024

Wei Lu, Shihan Zhou, Xueli Ma, Nuo Xu, Dongxin Liu, Keqing Zhang, Yongke Zheng, Shenghai Wu

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Antimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wei Lu *Department of Laboratory, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.ORCID 0009-0006-8953-9572
Shihan Zhou *The Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Xueli MaDepartment of Laboratory, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Nuo XuThe Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Dongxin LiuDepartment of Laboratory, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Keqing ZhangDepartment of Laboratory, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.
Yongke Zheng *The Fourth School of Medicine Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Shenghai Wu *Department of Laboratory, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China.ORCID 0000-0002-9923-1014
Zhejiang Chinese Medical University · CNWestlake University · CN

Funding

Medical and Health Technology Project of Hangzhou ZD20220012Zhejiang Provincial Medical and Health Technology Project 2024KY229
6 · The paper itself

Abstract

This study investigated resistance genes corresponding to the fosfomycin resistance phenotype in clinical isolate

Indexed as

FosfomycinAnti-Bacterial AgentsChromosomesEscherichia coliMicrobial Sensitivity TestsProvidenciaAnti-Bacterial AgentsFosfomycinfosA11fosfomycin resistanceglutathione-S transferaseProvidencia rettgeriwhole-genome sequencing

Identifiers

PMID38149860
PMCPMC10846113
OpenAlexW4390266492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.